Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Governor Patrick, Industry Representatives Join Navidea Biopharmaceuticals to Open New Business and Commercialization Facility in Andover, MA

Jun 7, 2012

Navidea Biopharmaceuticals Announces the Presentation of Data at Society of Nuclear Medicine Annual Meeting in June

Jun 6, 2012

Meta-analysis of Navidea Biopharmaceuticals Lymphoseek® Phase 3 Data Compared to Standard of Care Techniques Published in Conjunction with the ASCO Annual Meeting

Jun 4, 2012

Navidea Biopharmaceuticals to Present at the Jefferies 2012 Global Healthcare Conference

May 30, 2012

Presentation Highlights Clinical Potential of Navidea Biopharmaceuticals’ β-Amyloid Imaging Biomarker AZD4694

May 29, 2012

Navidea Biopharmaceuticals Announces the Presentation of Data at Several Upcoming Scientific Meetings

May 9, 2012

Navidea Biopharmaceuticals Announces First Quarter 2012 Results

May 2, 2012

Navidea Biopharmaceuticals First Quarter 2012 Earnings and Business Update Conference Call Invitation

Apr 27, 2012

Navidea Biopharmaceuticals Announces Participation in Alzheimer’s Disease Scientific Meetings

Apr 25, 2012

FDA Extends PDUFA Date for Lymphoseek® by Three Months

Apr 3, 2012
    • 1...
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    • 43
    © 2023 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap